Thndr Claps
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic
No Result
View All Result
Thndr Claps

Thndr Claps » U.S. Claps » Health & Pharma💉 » GSK set to acquire Sierra Oncology🦠

GSK set to acquire Sierra Oncology🦠

by Shams Abbas
April 12, 2022

The Clap
British healthcare giant GlaxoSmithKline (GSK) is set to acquire Sierra Oncology (NASDAQ: SRRA) for $1.9 billion.

More details
Sierra is a biopharmaceutical company that focuses on the treatment of rare forms of cancer. The offer came in at $55/share, a 39% premium to SRRA’s closing price yesterday.

Why this matters
The acquisition is set to complement some of GSK’s treatments, including Myeloma, a type of blood cancer.

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

Related Posts

Amazon, Revenue, Claps
Tech 📲

Amazon sets modest forecast ☁️

by Omar El Shorafa
February 3, 2023
Claps, Tech, NASDAQ
Tech 📲

Meta reports strong Q4 earnings 📱

by Omar El Shorafa
February 2, 2023
Intel, Chips, NASDAQ
Tech 📲

An underwhelming quarter from Intel 📉

by Omar El Shorafa
January 27, 2023
Claps, Health
Tech 📲

Amazon offer medical subscription service 💊

by Omar El Shorafa
January 25, 2023
Claps, Tech
Tech 📲

Microsoft posts bitter-sweet quarter 💻

by Omar El Shorafa
January 25, 2023
Claps, Tech
Tech 📲

Google to begin layoffs ✂️

by Omar El Shorafa
January 23, 2023

Website

Community

Blog

Learn

© Thndr. All rights reserved

No Result
View All Result
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic

Disclaimer: Thndr does not provide investment advice, individual investors are responsible for their own decisions or can seek independent advice. The value of investments can go up and down. Thndr is a trading name of Thndr Securities Brokerage which is authorised and regulated by the Financial Regulatory Authority (FRA). Registered in Egypt (no. 804)..© Thndr. All rights reserved

 

Hello👋 We want you to be able to express your opinions on anything and everything finance and economics related to the Egyptian and US markets.

This is why we introduced Thndr Thinkers💭

Let’s go through some housekeeping notes before you jump into publishing your article to all Thndr Claps readers!

Type of Content📝 We want to see market-relevant content that shows good analysis, please! Base your articles on facts 

Don’t be shy, explain🗣 Flex your knowledge to us, and we’ll share it with all the readers!

Be Original🙏 Please don’t copy. No one likes a copycat. All submissions are welcome as long as they’re yours 

Make your title attractive🤩 A title is like the cover of your book. Attractive enough to make you look at the book but also clear enough to tell you what the book is about.

Clean🧹 We’re all humans and we all make mistakes. But please try and clean up the article so it’s clear for all the readers 

No promotional content🚫 We don’t publish promotional content.

Any questions about becoming a Thndr Thinker? Email thndrclaps@thndr.app and we’d be happy to help!

Normally, your article will be published within 24 hours of submission (if you followed the guidelines)